Discover 162 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 162
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
for
HIV Infections
Location: Wilmington NC, Durham NC, Greensboro NC, Charlotte NC,
Sponsor: ViiV Healthcare
Sex: All
Age: 18+
Code: NCT07202546
Phase 2, Recruiting
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
for
Migraine
Location: Wilmington NC
Sponsor: Pfizer
Sex: Female
Age: 0+
Code: NCT05046613
Recruiting
IBD Pregnancy Registry
for
Inflammatory Bowel Disease (IBD)
Location: Wilmington NC
Sponsor: CorEvitas
Sex: Female
Age: 18 - 50
Code: NCT06910553
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Wilmington NC, Pinehurst NC, Durham NC, Fort Mill SC,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines
for
Upper Facial Lines, Glabellar Lines
Location: Wilmington NC, Arlington VA, Washington D.C. DC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07871513
Phase 2, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Wilmington NC, Greenville NC, Norfolk VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07415044
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Wilmington NC, Winston-Salem NC, Richmond VA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
for
Schizophrenia
Location: Rose Hill NC, Kinston NC, Fort Mill SC, Baltimore MD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07101094
Recruiting
ALTO-100 in Bipolar Disorder With Depression (BD-D)
for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Rose Hill NC, Cary NC, Fairfax VA, Gaithersburg MD,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT06656416
Phase 2, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Rose Hill NC, Winston-Salem NC, Fairfax VA,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase 2, Recruiting
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
for
Hypercholesterolaemia
Location: Little River SC, Monroe NC, Richmond VA, Manassas VA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07610278
Phase 2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Savannah GA, Washington D.C. DC, Millville DE,